SKYE
Skye Bioscience
$1.31
−$0.21 (−13.82%)Oct 29, 2026
Key metrics
The numbers that frame SKYE today
- Market cap
- $5.80M
- ROIC
- -912.8%
- Div yield
- 0%
- 52wk Low
- $1.25
- 52wk High
- $13.04
Growth
Revenue and earnings trend for SKYE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SKYE
Is Skye Bioscience a good buy?
No. Skye Bioscience has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of SKYE?
Skye Bioscience's market capitalization is $5.80M.
What is the 52-week high for SKYE stock?
The 52-week high for Skye Bioscience is $13.04. The current close of $1.31 is 90% below that high.
What is the 52-week low for SKYE stock?
The 52-week low for Skye Bioscience is $1.25. The current close of $1.31 is 4.8% above that low.
Does SKYE stock pay dividends?
Skye Bioscience does not currently show a dividend per share in the company data.